Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Szer

Showing results (181-190 of 195) with videos related to

Pageof 20
Sort By:
Internal Medicine Journal|December 9, 2014
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014S Fleming, C K Yannakou, G M Haeusler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factorR L Basser, L B To, C G Begley, et al.
Internal Medicine Journal|August 30, 2014
Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupN Weber, P Mollee, B Augustson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-upR L Basser, L B To, J P Collins, et al.
Blood|March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemiaJ F Bishop, J P Matthews, G A Young, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global surveyD Niederwieser, H Baldomero, J Szer, et al.
Bone Marrow Transplantation|July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)J P Halter, S M van Walraven, N Worel, et al.
British Journal of Haematology|June 19, 2001
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemiaJ P Matthews, J F Bishop, G A Young, et al.
Bone Marrow Transplantation|October 12, 2011
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysisH J Khoury, M Kukreja, J M Goldman, et al.
Bone Marrow Transplantation|January 24, 2017
Latin America: the next region for haematopoietic transplant progressG Jaimovich, J Martinez Rolon, H Baldomero, et al.
Pageof 20

Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
Internal Medicine Journal|December 9, 2014
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014S Fleming, C K Yannakou, G M Haeusler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factorR L Basser, L B To, C G Begley, et al.
Internal Medicine Journal|August 30, 2014
Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupN Weber, P Mollee, B Augustson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-upR L Basser, L B To, J P Collins, et al.
Blood|March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemiaJ F Bishop, J P Matthews, G A Young, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global surveyD Niederwieser, H Baldomero, J Szer, et al.
Bone Marrow Transplantation|July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)J P Halter, S M van Walraven, N Worel, et al.
British Journal of Haematology|June 19, 2001
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemiaJ P Matthews, J F Bishop, G A Young, et al.
Bone Marrow Transplantation|October 12, 2011
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysisH J Khoury, M Kukreja, J M Goldman, et al.
Bone Marrow Transplantation|January 24, 2017
Latin America: the next region for haematopoietic transplant progressG Jaimovich, J Martinez Rolon, H Baldomero, et al.
Pageof 20